IE38423B1 - Vaccine for nenatal calf diarrhea - Google Patents

Vaccine for nenatal calf diarrhea

Info

Publication number
IE38423B1
IE38423B1 IE1925/73A IE192573A IE38423B1 IE 38423 B1 IE38423 B1 IE 38423B1 IE 1925/73 A IE1925/73 A IE 1925/73A IE 192573 A IE192573 A IE 192573A IE 38423 B1 IE38423 B1 IE 38423B1
Authority
IE
Ireland
Prior art keywords
vaccine
calf diarrhea
diarrhea
nenatal
bovine
Prior art date
Application number
IE1925/73A
Other languages
English (en)
Other versions
IE38423L (en
Original Assignee
Univ Nebraska
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Nebraska filed Critical Univ Nebraska
Publication of IE38423L publication Critical patent/IE38423L/xx
Publication of IE38423B1 publication Critical patent/IE38423B1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/15—Reoviridae, e.g. calf diarrhea virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5254—Virus avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505—Inorganic adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/70—Multivalent vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2720/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsRNA viruses
    • C12N2720/00011—Details
    • C12N2720/12011—Reoviridae
    • C12N2720/12034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/20011—Coronaviridae
    • C12N2770/20034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IE1925/73A 1972-10-30 1973-10-26 Vaccine for nenatal calf diarrhea IE38423B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30217972A 1972-10-30 1972-10-30

Publications (2)

Publication Number Publication Date
IE38423L IE38423L (en) 1974-04-30
IE38423B1 true IE38423B1 (en) 1978-03-15

Family

ID=23166611

Family Applications (1)

Application Number Title Priority Date Filing Date
IE1925/73A IE38423B1 (en) 1972-10-30 1973-10-26 Vaccine for nenatal calf diarrhea

Country Status (17)

Country Link
JP (3) JPS5817169B2 (cg-RX-API-DMAC7.html)
AR (1) AR200155A1 (cg-RX-API-DMAC7.html)
AU (1) AU476160B2 (cg-RX-API-DMAC7.html)
BE (1) BE806568A (cg-RX-API-DMAC7.html)
CA (1) CA1019675A (cg-RX-API-DMAC7.html)
CH (1) CH596315A5 (cg-RX-API-DMAC7.html)
DD (1) DD110517A5 (cg-RX-API-DMAC7.html)
DE (1) DE2354324C2 (cg-RX-API-DMAC7.html)
ES (1) ES419996A1 (cg-RX-API-DMAC7.html)
FI (1) FI52740C (cg-RX-API-DMAC7.html)
FR (1) FR2204405B1 (cg-RX-API-DMAC7.html)
GB (1) GB1401565A (cg-RX-API-DMAC7.html)
HU (1) HU168486B (cg-RX-API-DMAC7.html)
IE (1) IE38423B1 (cg-RX-API-DMAC7.html)
NL (1) NL7314293A (cg-RX-API-DMAC7.html)
SE (1) SE419500B (cg-RX-API-DMAC7.html)
ZA (1) ZA738329B (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6027007U (ja) * 1983-07-30 1985-02-23 株式会社　協立双葉自動機 容器回転速度調整装置付きラベリングマシン
JPH0518338Y2 (cg-RX-API-DMAC7.html) * 1985-12-27 1993-05-17
ZA872532B (en) * 1986-04-21 1987-11-25 Akzo Nv Combined vaccine
US6291228B1 (en) 1988-08-03 2001-09-18 Vericore Limited Vaccine
GB8818415D0 (en) * 1988-08-03 1988-09-07 Animal Health Inst Vaccine
JPH08786B2 (ja) * 1993-02-25 1996-01-10 株式会社微生物化学研究所 牛コロナウイルス感染症ワクチン
US10808227B2 (en) 2015-11-06 2020-10-20 Asahi Kasei Medical Co., Ltd. Method for producing parvovirus having high infectivity titer and high purity

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE759425A (fr) * 1969-11-28 1971-05-25 Mebus Charles A Vaccins contre la diarrhee du veau, leur preparation et emploi
US3629413A (en) * 1970-02-04 1971-12-21 Univ Southern Illinois Polyvalent bovine vaccines and methods of making and using same

Also Published As

Publication number Publication date
DD110517A5 (cg-RX-API-DMAC7.html) 1974-12-20
DE2354324A1 (de) 1974-05-09
IE38423L (en) 1974-04-30
CH596315A5 (cg-RX-API-DMAC7.html) 1978-03-15
AR200155A1 (es) 1974-10-24
JPS4980230A (cg-RX-API-DMAC7.html) 1974-08-02
JPS5817169B2 (ja) 1983-04-05
FI52740B (cg-RX-API-DMAC7.html) 1977-08-01
AU476160B2 (en) 1976-09-16
HU168486B (en) 1976-05-28
BE806568A (fr) 1974-04-26
CA1019675A (en) 1977-10-25
FI52740C (fi) 1977-11-10
ES419996A1 (es) 1976-08-01
JPS5757449B2 (cg-RX-API-DMAC7.html) 1982-12-04
FR2204405A1 (cg-RX-API-DMAC7.html) 1974-05-24
FR2204405B1 (cg-RX-API-DMAC7.html) 1977-01-28
ZA738329B (en) 1974-09-25
NL7314293A (cg-RX-API-DMAC7.html) 1974-05-02
SE419500B (sv) 1981-08-10
DE2354324C2 (de) 1982-06-03
AU6177473A (en) 1975-04-24
JPS5531058A (en) 1980-03-05
JPS6124370B2 (cg-RX-API-DMAC7.html) 1986-06-10
JPS57131726A (en) 1982-08-14
GB1401565A (en) 1975-07-16

Similar Documents

Publication Publication Date Title
LV10203A (lv) Panemiens inficesanas ar AIDS noteiksanai olbaltumvielu kompozicija test-komplekts
ES2179105T3 (es) Adyuvantes proteinicos.
DE3072205D1 (de) Dns-transfer-vektor, damit transformierter wirt, impfstoff und ihre herstellung.
CA2022420A1 (en) Escherichia coli vaccine
FI823021A7 (fi) Tuotteet, jotka osoittavat hepatitis B virus e antigeenin antigeenisuuden ja menetelmät näiden antigeenien vavalmistamiseksi.
ATE173166T1 (de) Neue bakterielle impfstoffe unter verwendung von impfstämmen von pathogenen bakterien
NO912825D0 (no) Fremgangsmaate for fremstilling av cokonjugate vaksiner omfattende immunogenisk protein, hiv-beslektede peptider og anioniske grupper.
IE38423B1 (en) Vaccine for nenatal calf diarrhea
IT1044555B (it) Benzodipironi e procedimento per prepararli
ES477212A1 (es) Un procedimiento para la preparacion de una enterotoxina.
TW340873B (en) Chicken anaemia agent vaccine
CA961410A (en) Live attenuated infectious bovine rhinotracheitis virus vaccines and preparation thereof
DE3064768D1 (de) Anticolibacillary animal vaccine, preparation, application and used escherichia coli strains
SE9604322D0 (sv) Bacterial antigens and vaccine compositions II
AU558008B2 (en) Ozone inactivated organisms as vaccines
NL300073I1 (nl) Vaccin.
IT8020442A0 (it) Procedimento, impiego dello stesso e dispositivo per la manipolazione di prodotti stampati.
GB1036621A (en) Improvements in or relating to bacterial vaccines
SE7711433L (sv) Tricykliska foreningar
SU565653A1 (ru) Способ консервировани костной ткани
GB949400A (en) Poliomyelitis vaccines
before Parliament et al. The Industrial Relations (Code of Practice) Order 1972
JPS53109912A (en) Condensed tannin, inactivation of microorganism-originated toxic substance, and attenuation of vaccines using condensed tannin
Nicolas et al. Attempt of Vaccination Program Against Sheep Salmonellosis due to Salmonella abortus ovis.
MOVEMENT Ol\1MONWEALTH COLLEGE: STUDENT ACTIVISM AND THE I SOUTHERN AGRICULTURAL LABOR MOVEMENT, 1923-1940